These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 37851364)
1. The HNF4A-CHPF pathway promotes proliferation and invasion through interactions with MAD1L1 in glioma. Luo H; Huang K; Cheng M; Long X; Zhu X; Wu M Aging (Albany NY); 2023 Oct; 15(20):11052-11066. PubMed ID: 37851364 [TBL] [Abstract][Full Text] [Related]
2. Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1. Sun W; Zhao F; Xu Y; Huang K; Guo X; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Schadendorf D; Chen Y Cell Death Dis; 2020 Jul; 11(7):496. PubMed ID: 32612115 [TBL] [Abstract][Full Text] [Related]
3. Chondroitin polymerizing factor (CHPF) contributes to malignant proliferation and migration of hepatocellular carcinoma cells. Xu Q; Lin W; Tao C; Huang X; Li J Biochem Cell Biol; 2020 Jun; 98(3):362-369. PubMed ID: 32383983 [TBL] [Abstract][Full Text] [Related]
4. CHPF promotes gastric cancer tumorigenesis through the activation of E2F1. Lin X; Han T; Xia Q; Cui J; Zhuo M; Liang Y; Su W; Wang L; Wang L; Liu Z; Xiao X Cell Death Dis; 2021 Sep; 12(10):876. PubMed ID: 34564711 [TBL] [Abstract][Full Text] [Related]
5. Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers. Li Y; Gong H; Feng L; Mao D; Xiao Y; Wang Y; Huang L FEBS Open Bio; 2021 Feb; 11(2):423-434. PubMed ID: 33301643 [TBL] [Abstract][Full Text] [Related]
6. Chondroitin Polymerizing Factor (CHPF) promotes cell proliferation and tumor growth in human osteosarcoma by inhibiting SKP2's ubiquitination while activating the AKT pathway. Shen Y; Li J; Peng D; Liao L; Chen X; Zhong W; Liu Z; Yu C; Sun Y Genes Dis; 2023 Sep; 10(5):2125-2136. PubMed ID: 37492722 [TBL] [Abstract][Full Text] [Related]
7. Chondroitin polymerizing factor promotes development and progression of colorectal cancer via facilitating transcription of VEGFB. Huang Y; Zhang Z; Tong H; Qin W; Li Q; Ma L; Ren Z; Chen W; Zhang Y; Zhong Y; Yao L; Zhou P J Cell Mol Med; 2024 May; 28(10):e18268. PubMed ID: 38775031 [TBL] [Abstract][Full Text] [Related]
8. Lentivirus‑mediated knockdown of chondroitin polymerizing factor inhibits glioma cell growth in vitro. Fan YH; Xiao B; Lv SG; Ye MH; Zhu XG; Wu MJ Oncol Rep; 2017 Aug; 38(2):1149-1155. PubMed ID: 28627702 [TBL] [Abstract][Full Text] [Related]
9. Identification of chondroitin polymerizing factor (CHPF) as tumor promotor in cholangiocarcinoma through regulating cell proliferation, cell apoptosis and cell migration. Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X Cell Cycle; 2021; 20(5-6):591-602. PubMed ID: 33651657 [TBL] [Abstract][Full Text] [Related]
10. Expression of CHPF modulates cell proliferation and invasion in lung cancer. Cao C; Liu Y; Wang Q; Zhao J; Shi M; Zheng J Braz J Med Biol Res; 2020; 53(5):e9021. PubMed ID: 32348423 [TBL] [Abstract][Full Text] [Related]
11. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter. Zhang J; Yang Y; Dong Y; Liu C Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078 [TBL] [Abstract][Full Text] [Related]
12. Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan-1 expression. Yen HR; Liao WC; Chen CH; Su YA; Huang YW; Hsiao C; Chou YL; Chu YH; Shih PK; Liu CH Mol Oncol; 2024 Oct; 18(10):2569-2585. PubMed ID: 38770553 [TBL] [Abstract][Full Text] [Related]
13. Chondroitin polymerizing factor predicts a poor prognosis and promotes breast cancer progression via the upstream TGF-β1/SMAD3 and JNK axis activation. Pan QF; Ouyang WW; Zhang MQ; He S; Yang SY; Zhang J J Cell Commun Signal; 2023 Mar; 17(1):89-102. PubMed ID: 36042157 [TBL] [Abstract][Full Text] [Related]
14. MiR-214-3p overexpression-triggered chondroitin polymerizing factor (CHPF) inhibition modulates the ferroptosis and metabolism in colon cancer. Yun ZY; Wu D; Wang X; Huang P; Li N Kaohsiung J Med Sci; 2024 Mar; 40(3):244-254. PubMed ID: 38190270 [TBL] [Abstract][Full Text] [Related]
15. CHPF Regulates the Aggressive Phenotypes of Hepatocellular Carcinoma Cells via the Modulation of the Decorin and TGF-β Pathways. Liu CH; Wu BR; Ho YJ; Chu YH; Hsu WC; Tseng TJ; Li JP; Liao WC Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809195 [TBL] [Abstract][Full Text] [Related]
16. Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer. Li WW; Liu B; Dong SQ; He SQ; Liu YY; Wei SY; Mou JY; Zhang JX; Liu Z Front Oncol; 2022; 12():856712. PubMed ID: 35372047 [TBL] [Abstract][Full Text] [Related]
17. Chondroitin polymerizing factor (CHPF) promotes the progression of colorectal cancer through ASB2-mediated ubiquitylation of SMAD9. Zhao J; Tang X; Zhu H Histol Histopathol; 2024 Nov; 39(11):1493-1503. PubMed ID: 38591191 [TBL] [Abstract][Full Text] [Related]
18. Exploring the correlation of glycolysis-related chondroitin polymerizing factor ( Zhong Q; Jiang K; Zhang F; Tian Y; Gu J; Li T; Chen X; Yang J; Sun F Am J Cancer Res; 2023; 13(6):2213-2233. PubMed ID: 37424829 [TBL] [Abstract][Full Text] [Related]
19. Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization. Kitagawa H; Izumikawa T; Uyama T; Sugahara K J Biol Chem; 2003 Jun; 278(26):23666-71. PubMed ID: 12716890 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the role of CHPF in colorectal cancer tumorigenesis and immunotherapy based on bioinformatics and experiments. Song Q; Wang P; Wu J; Lu M; Xia Q; Shi Y; Wang Z; Ma X; Zhao Q Discov Oncol; 2024 Sep; 15(1):458. PubMed ID: 39292317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]